SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-050612
Filing Date
2024-04-30
Accepted
2024-04-30 17:00:15
Documents
11
Period of Report
2024-04-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20240426.htm   iXBRL 8-K 42276
  Complete submission text file 0000950170-24-050612.txt   167433

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20240426.xsd EX-101.SCH 31969
14 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20240426_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 24898281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)